image
4D Molecular Therapeutics, Inc. FDMT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 8.83
10.1 %
$ 408 M
Market Cap
-3.94
P/E
INCOME STATEMENT
20.7 M REVENUE
562.29%
Growth Rates
1Year 562.29%
3Years 15.04%
5Years 7.96%
7Years 0.00%
10Years 0.00%
-113 M OPERATING INCOME
-2.58%
Growth Rates
1Year -2.58%
3Years -25.82%
5Years -61.11%
7Years 0.00%
10Years 0.00%
-101 M NET INCOME
6.19%
Growth Rates
1Year 6.19%
3Years -21.16%
5Years -60.22%
7Years 0.00%
10Years 0.00%
EFFICIENCY
Earnings Waterfall 4D Molecular Therapeutics, Inc.
image
Revenue 20.7 M
Cost Of Revenue 97.1 M
Gross Profit -76.4 M
Operating Expenses 134 M
Operating Income -113 M
Other Expenses -12 M
Net Income -101 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
REVENUE
Revenue 20.7 3.1 18.0 13.6 7.0 14.1 5.8
GROSS PROFIT
Cost Of Revenue 97.1 3.9 3.0 53.0 38.7 18.4 13.6
Gross Profit (76.4) (0.8) 15.0 (39.4) (31.7) (4.2) (7.8)
OPERATING INCOME
Operating Expenses 133.6 113.2 89.4 70.3 52.6 24.5 17.1
Selling, General and Administrative Expenses 36.5 32.9 28.0 17.2 13.9 6.2 3.5
Research and Development Expenses 97.1 80.3 61.4 53.0 38.7 18.4 13.6
Operating Income (112.9) (110.0) (71.3) (56.7) (50.8) (10.4) (11.3)
PRE-TAX INCOME
Interest Income Expense 0 0 0 0 0 0 0
Total Other Income 12.0 2.5 16 K 29 K 1.5 0.8 49 K
Pre-Tax Income (100.8) (107.5) (71.3) (56.7) (49.3) (9.6) (11.2)
NET INCOME
Tax Provision 0 (6.4) (3.0) (0.2) 3.6 0.8 89 K
Net Income (100.8) (101.1) (68.3) (56.5) (52.9) (9.6) (11.2)
EPS 2.58 3.12 2.46 2.12 2 0.76 0.76